将铁亡转化为瘤学:挑战,机遇和未来方向
Rui Kang1, Jiao Liu2, Jiayi Wang3,4
1Department of Surgery, UT Southwestern Medical Center, Dallas, TX, USA. rui.kang@utsouthwestern.edu.
Nature reviews. Clinical oncology
|February 24, 2026
概括
细胞死亡途径铁灭,在癌症治疗中表现有前途,但面临临临床翻译障碍. 本综述探讨了基于铁灭的癌症治疗的挑战和机遇.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 铁亡是一种受调节的细胞死亡途径,由脂质过氧化驱动.
- 它在癌症中起着复杂的作用,既可以抑制瘤,也可以促进瘤.
- 铁灭的治疗向对癌症研究具有重要意义.
研究的目的:
- 审查阻碍基于ferroptosis的癌症疗法的临床转化障碍.
- 识别新出现的机会和战略,以推进铁灭症治疗方法.
- 提出一个路线图,将铁化整合到临床瘤实践中.
主要方法:
- 关于癌症中的铁亡的综合文献综述.
- 对ferroptosis诱导剂的临床前和临床数据的分析.
- 检查挑战,包括药理学,生物学和免疫学因素.
主要成果:
- 铁灭症研究中的显著临床前进展与新生的临床翻译形成鲜明对比.
- 关键障碍包括药物输送,瘤异质性,微环境和免疫逃避.
- 新兴的机会涉及新型药物,生物标志物和组合疗法.
结论:
- 铁化有可能成为瘤学中的治疗策略.
- 克服转化障碍对于临床应用至关重要.
- 需要制定战略路线图,以加快基于铁灭的癌症治疗开发.
相关概念视频
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
Cancer Therapies
10.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Translation
18.9K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
18.9K

